Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) has been regarded as the standard treatment regimen for classical Hodgkin lymphoma. In recent years, ABVD-like regimens, which emerged due to shortages and the lung toxicity of bleomycin or the emergence of immune checkpoint inhibitors and ...
The meaning of ABVD is a chemotherapy drug regimen of doxorubicin (trademark name Adriamycin), bleomycin, vinblastine, and dacarbazine that is used in the treatment of Hodgkin's lymphoma. How to use ABVD in a sentence.
ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) is the most widely used regimen for the treatment of early and advanced stage Hodgkin lymphoma (HL). Treatment of patients with early stage classical HL evolved over the last three decades. Radiation therapy alone as the single treatment ...
and Dacarbazine (ABVD) is the most commonly used chemotherapy regime for Hodgkin lymphoma. This highly effective treatment is associated with a significant risk of neutropenia. Various strategies are adopted to counter this commonly encountered problem, including dose modification, use of colony stimulatin...
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim re... The HD9 trial aims to evaluate whether moderate dose escalation and/or acceleration of standard polychemotherapy is beneficial for advance...
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned. BACKGROUND: BEACOPP, an intensified regimen consisting of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone, h... S Viviani,P Zinzani,A Rambaldi,... - 《New England Journal ...
WEIXiao鄄juan2Keywords:Hodgkinlymphoma;BEACOPPregimen;ABVDregimenReviewer’saddress:LymphomaDepartment,BeijingCancerHospital,PekingUniversity,Beijing100142,China1文献来源VivianiS,ZinzaniPL,RambaldiA,etal.ABVDversusBEACOPPforHodgkin蒺s lymphomawhenhigh鄄dosesalvageisplanned[J].NEnglJMed,2011,365(3):203-212.2证据...
UK and 6Department of Medical Oncology, Southampton General Hospital, Southampton, UK Background: Myelotoxicity during initial cycles of chemotherapy for Hodgkin lymphoma is associated with better outcome, supporting the concept of individualised dosing based on pharmacodynamic end points to optimise results...
Conclusions: The preferred treatment strategy for patients with newly diagnosed advanced‐stage Hodgkin lymphoma is the AHL2011 PET‐adapted regimen. This strategy maximizes life expectancy, quality‐adjusted life years, and is the most cost‐effective strategy, accounting for increased rates of ...
Combined modality treatment is the standard treatment for intermediate stage Hodgkin's lymphoma (HL). Despite high complete remission (CR) rates, failure rates are remarkably higher in this group of patients. In the HD 11 multicenter trial of the GHSG the BEACOPP regimen was introduced to interme...